Logo image of GDNP.CA

GOOD NATURED PRODUCTS INC (GDNP.CA) Stock Fundamental Analysis

TSX-V:GDNP - TSX Venture Exchange - CA38210L1094 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

2

GDNP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 28 industry peers in the Chemicals industry. Both the profitability and financial health of GDNP have multiple concerns. While showing a medium growth rate, GDNP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GDNP has reported negative net income.
GDNP had a negative operating cash flow in the past year.
GDNP had negative earnings in each of the past 5 years.
GDNP had negative operating cash flow in 4 of the past 5 years.
GDNP.CA Yearly Net Income VS EBIT VS OCF VS FCFGDNP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -19.62%, GDNP is doing worse than 61.76% of the companies in the same industry.
The Return On Equity of GDNP (-306.81%) is worse than 82.35% of its industry peers.
Industry RankSector Rank
ROA -19.62%
ROE -306.81%
ROIC N/A
ROA(3y)-13.74%
ROA(5y)-16.65%
ROE(3y)-99.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GDNP.CA Yearly ROA, ROE, ROICGDNP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500

1.3 Margins

The Gross Margin of GDNP (26.12%) is better than 82.35% of its industry peers.
GDNP's Gross Margin has declined in the last couple of years.
GDNP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.16%
GM growth 5Y-5.04%
GDNP.CA Yearly Profit, Operating, Gross MarginsGDNP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

0

2. Health

2.1 Basic Checks

GDNP does not have a ROIC to compare to the WACC, probably because it is not profitable.
GDNP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GDNP has been increased compared to 5 years ago.
Compared to 1 year ago, GDNP has a worse debt to assets ratio.
GDNP.CA Yearly Shares OutstandingGDNP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
GDNP.CA Yearly Total Debt VS Total AssetsGDNP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -0.62, we must say that GDNP is in the distress zone and has some risk of bankruptcy.
GDNP's Altman-Z score of -0.62 is on the low side compared to the rest of the industry. GDNP is outperformed by 64.71% of its industry peers.
A Debt/Equity ratio of 9.65 is on the high side and indicates that GDNP has dependencies on debt financing.
GDNP has a worse Debt to Equity ratio (9.65) than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 9.65
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACC7.78%
GDNP.CA Yearly LT Debt VS Equity VS FCFGDNP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.84 indicates that GDNP may have some problems paying its short term obligations.
GDNP's Current ratio of 0.84 is in line compared to the rest of the industry. GDNP outperforms 44.12% of its industry peers.
A Quick Ratio of 0.44 indicates that GDNP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.44, GDNP is in line with its industry, outperforming 41.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.44
GDNP.CA Yearly Current Assets VS Current LiabilitesGDNP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GDNP have decreased strongly by -20.00% in the last year.
Looking at the last year, GDNP shows a very negative growth in Revenue. The Revenue has decreased by -26.23% in the last year.
The Revenue has been growing by 71.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.76%
Revenue 1Y (TTM)-26.23%
Revenue growth 3Y66.1%
Revenue growth 5Y71.89%
Sales Q2Q%-30.74%

3.2 Future

GDNP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.27% yearly.
GDNP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.31% yearly.
EPS Next Y32.67%
EPS Next 2Y22.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.63%
Revenue Next 2Y11.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GDNP.CA Yearly Revenue VS EstimatesGDNP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GDNP.CA Yearly EPS VS EstimatesGDNP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.02 -0.04 -0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GDNP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GDNP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GDNP.CA Price Earnings VS Forward Price EarningsGDNP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GDNP.CA Per share dataGDNP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

A more expensive valuation may be justified as GDNP's earnings are expected to grow with 22.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GDNP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GOOD NATURED PRODUCTS INC

TSX-V:GDNP (10/23/2024, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-02 2024-09-02
Earnings (Next)11-27 2024-11-27
Inst Owners0.36%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.83M
Analysts80
Price Target0.2 (3900%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.19
BVpS0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.62%
ROE -306.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.12%
FCFM N/A
ROA(3y)-13.74%
ROA(5y)-16.65%
ROE(3y)-99.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.16%
GM growth 5Y-5.04%
F-Score1
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 9.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.69%
Cap/Sales 3.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.44
Altman-Z -0.62
F-Score1
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)301.04%
Cap/Depr(5y)242.98%
Cap/Sales(3y)8.84%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.76%
EPS Next Y32.67%
EPS Next 2Y22.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.23%
Revenue growth 3Y66.1%
Revenue growth 5Y71.89%
Sales Q2Q%-30.74%
Revenue Next Year6.63%
Revenue Next 2Y11.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.91%
EBIT Next 3Y52.06%
EBIT Next 5Y45.76%
FCF growth 1Y42.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.85%
OCF growth 3YN/A
OCF growth 5YN/A